Macrogenics Inc

NASDAQ:MGNX   1:25:00 PM EDT
6.46
+0.54 (+9.12%)
Products

MacroGenics Earns $60 Mln Milestone With U.S. FDA Approval Of Teplizumab

Published: 11/17/2022 23:29 GMT
Macrogenics Inc (MGNX) - Macrogenics Earns $60 Million Milestone With U.S. FDA Approval of Teplizumab.